Contemporary surveillance of sinonasal malignancy in adults

Abstract

Sinonasal malignancies are a unique subset of head and neck cancers that necessitate close monitoring due to high local recurrence rates. Surveillance consists of a combination of endoscopy, imaging, and patient-reported symptomatology, but no standardized surveillance protocols currently exist. Strategies historically have been based on guidelines for other head and neck malignancies; however, the unique anatomical and histologic presentation of sinonasal malignancies presents challenges. This review discusses the literature surrounding the utility of each of the different surveillance modalities and highlights techniques under investigation to aid clinicians in optimizing the surveillance of sinonasal malignancies.

Keywords

Sinonasal cancer / sinonasal squamous cell carcinoma / sinonasal adenocarcinoma / sinonasal endocrine carcinoma / sinonasal malignancy / sinonasal undifferentiated carcinoma / surveillance

References

[1] Abdou R.Population-based results in the management of sinonasal and ventral skull base malignancies.Otolaryngol Clin North Am2017;50:481-97

[2] Sharma RK,Schlosser RJ.Conditional and overall disease-specific survival in patients with paranasal sinus and nasal cavity cancer: improved outcomes in the endoscopic era.Am J Rhinol Allergy2022;36:57-64

[3] Mirghani H,Armas GL.Sinonasal cancer: analysis of oncological failures in 156 consecutive cases.Head Neck2014;36:667-74

[4] Li X,Di B.[Recurrence and surgical salvage of sinonasal squamous cell carcinoma].Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi2013;48:186-90

[5] Bossi P,Lechner M.Precision medicine in rare tumors and the need for multicenter trials and international collaboratives: sinonasal cancer as paradigm.Oral Oncol2020;109:104737

[6] Katz TS,Morris CG,Hinerman RW.Malignant tumors of the nasal cavity and paranasal sinuses.Head Neck2002;24:821-9

[7] Harvey RJ,Nissman DB.PET/CT in the assessment of previously treated skull base malignancies.Head Neck2010;32:76-84

[8] de Visscher AVM, Manni JJ. Routine long-term follow-up in patients treated with curative intent for squamous cell carcinoma of the larynx, pharynx, and oral cavity. Does it make sense?.Arch Otolaryngol Head Neck Surg1994;120:934-9

[9] Dutta R,Svider PF,Baredes S.Sinonasal malignancies: a population-based analysis of site-specific incidence and survival.Laryngoscope2015;125:2491-7

[10] Porceddu S,Shanker G.Paranasal sinus tumors: Peter MacCallum Cancer Institute experience.Head Neck2004;26:322-30

[11] Suárez C,Lund VJ.Management of the orbit in malignant sinonasal tumors.Head Neck2008;30:242-50

[12] Pfister DG,Adelstein D.Head and neck cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw2020;18:873-98

[13] Workman AD,Adappa ND.Posttreatment surveillance for sinonasal malignancy.Curr Opin Otolaryngol Head Neck Surg2017;25:86-92

[14] Nyquist GG,Vimawala S.Surgery with post-operative endoscopy improves recurrence detection in sinonasal malignancies.Ann Otol Rhinol Laryngol2022;131:140-6

[15] Khalili S,Brooks S.Endoscopy versus imaging: analysis of surveillance methods in sinonasal malignancy.Head Neck2016;38:1229-33

[16] Zocchi J,Campomagnani I.The role of a post therapeutic surveillance program for sinonasal malignancies: analysis of 417 patients.Head Neck2020;42:963-73

[17] Schwartz JS,Stubbs V.Temporal patterns of ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography sinonasal uptake after treatment of sinonasal malignancy.Int Forum Allergy Rhinol2016;6:1301-7

[18] Chao SS,Tan LKS.Modalities of surveillance in treated nasopharyngeal cancer.Otolaryngol Head Neck Surg2003;129:61-4

[19] Thawani R,Arastu A.The contemporary management of cancers of the sinonasal tract in adults.CA Cancer J Clin2023;73:72-112 PMCID:PMC9840681

[20] Guevara-Canales JO,Sacsaquispe-Contreras SJS,Morales-Vadillo R.Malignant melanoma of the oral cavity. Review of the literature and experience in a Peruvian Population.Med Oral Patol Oral Cir Bucal2012;17:e206-11 PMCID:PMC3448307

[21] Maroldi R,Farina D.Post-treatment evaluation of paranasal sinuses after treatment of sinonasal neoplasms.Neuroimaging Clin N Am2015;25:667-85

[22] Kubota K,Yamaguchi K.FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy: comparison with MRI/CT.Eur J Nucl Med Mol Imaging2004;31:590-5

[23] Lund VJ,Nicolai P.European position paper on endoscopic management of tumours of the nose, paranasal sinuses and skull base. Rhinol Suppl 2010;22:1-143.

[24] Loevner LA.Imaging of neoplasms of the paranasal sinuses.Magn Reson Imaging Clin N Am2002;10:467-93

[25] Ng SH,Ko SF,Chong VFH.Posttreatment imaging of the nasopharynx.Eur J Radiol2002;44:82-95

[26] Ahmad S,Chiu AG.Incidence of intracranial radiation necrosis following postoperative radiation therapy for sinonasal malignancies.Laryngoscope2016;126:2445-50

[27] Oysu AS, Ayanoglu E, Kodalli N, Oysu C, Uneri C, Erzen C. Dynamic contrast-enhanced MRI in the differentiation of posttreatment fibrosis from recurrent carcinoma of the head and neck.Clin Imaging2005;29:307-12

[28] Tangyoosuk T,Jittapiromsak N.Utility of diffusion-weighted magnetic resonance imaging in predicting the treatment response of nasopharyngeal carcinoma.Neuroradiol J2022;35:477-85 PMCID:PMC9437492

[29] Galbán CJ,Chenevert TL.A feasibility study of parametric response map analysis of diffusion-weighted magnetic resonance imaging scans of head and neck cancer patients for providing early detection of therapeutic efficacy.Transl Oncol2009;2:184-90 PMCID:PMC2730136

[30] Vandecaveye V,De Keyzer F.Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for head and neck squamous cell carcinoma.Eur Radiol2010;20:1703-14

[31] Kawaguchi M,Tomita H.Imaging characteristics of malignant sinonasal tumors.J Clin Med2017;6:116 PMCID:PMC5742805

[32] Bair RJ,Chauhan NR,Madan R.Demystifying NUT midline carcinoma: radiologic and pathologic correlations of an aggressive malignancy.AJR Am J Roentgenol2014;203:W391-9

[33] de González AB,Kim KP.Projected cancer risks from computed tomographic scans performed in the United States in 2007.Arch Intern Med2009;169:2071-7 PMCID:PMC6276814

[34] Brenner DJ.Computed tomography - an increasing source of radiation exposure.N Engl J Med2007;357:2277-84

[35] Lee JC,Lee JH.F-18 FDG-PET as a routine surveillance tool for the detection of recurrent head and neck squamous cell carcinoma.Oral Oncol2007;43:686-92

[36] Anzai Y,Quint DJ.Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18]fluoro-D-glucose PET and MR imaging diagnoses.Radiology1996;200:135-41

[37] Villar R,Acosta M,Gómez A.Recurrent adenocarcinoma of the sinonasal tract.Oral Maxillofac Surg2013;17:155-8

[38] Kubota R,Kubota K,Tamahashi N.Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography.J Nucl Med1992;33:1972-80

[39] Reinhardt MJ,Yamada S,Yaegashi H.Assessment of cancer recurrence in residual tumors after fractionated radiotherapy: a comparison of fluorodeoxyglucose, L-methionine and thymidine.J Nucl Med1997;38:280-7

[40] Abgral R,Potard G.Does 18F-FDG PET/CT improve the detection of posttreatment recurrence of head and neck squamous cell carcinoma in patients negative for disease on clinical follow-up?.J Nucl Med2009;50:24-9

[41] Workman AD,Parasher AK.¹⁸FDG PET/CT in routine surveillance of asymptomatic patients following treatment of sinonasal neoplasms.Otolaryngol Head Neck Surg2017;157:1068-74

[42] Isles MG,Mehanna HM.A systematic review and meta-analysis of the role of positron emission tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy.Clin Otolaryngol2008;33:210-22

[43] Keski-Säntti H,Schildt J,Mäkitie AA.FDG-PET/CT in the assessment of treatment response after oncologic treatment of head and neck squamous cell carcinoma.Clin Med Insights Ear Nose Throat2014;7:25-9 PMCID:PMC4149379

[44] Gupta T,Kannan S.Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis.Eur J Nucl Med Mol Imaging2011;38:2083-95

[45] Gil Z,Margalit N.Integrated PET/CT system for staging and surveillance of skull base tumors.Head Neck2007;29:537-45

[46] Abu-Ghanem S,Ghanayem M,Yehuda M.Utility of first positron emission tomography-computed tomography scan as a prognostic tool following treatment of sinonasal and skull base malignancies.Head Neck2019;41:701-6

[47] Ozturk K,Caicedo-Granados E,Cayci Z.Performance of whole-body ¹⁸F-FDG PET/CT as a posttreatment surveillance tool for sinonasal malignancies.Eur Arch Otorhinolaryngol2019;276:847-55

[48] Akay S,Saad Eddin A.PET/CT imaging in treatment planning and surveillance of sinonasal neoplasms.Cancers2023;15:3759 PMCID:PMC10417627

[49] Patel TD,Dubal PM,Liu JK.Sinonasal neuroendocrine carcinoma: a population-based analysis of incidence and survival.Int Forum Allergy Rhinol2015;5:448-53

[50] van der Laan TP, Iepsma R, Witjes MJH, van der Laan BFAM, Plaat BEC, Halmos GB. Meta-analysis of 701 published cases of sinonasal neuroendocrine carcinoma: the importance of differentiation grade in determining treatment strategy.Oral Oncol2016;63:1-9

[51] Liu KY,Ninan SJ.The value of ⁶⁸Gallium-DOTATATE PET/CT in sinonasal neuroendocrine tumor management: a case series.Head Neck2021;43:E30-40

[52] Roytman M,Kacker A.[68Ga]-DOTATATE PET/CT and PET/MRI in the diagnosis and management of esthesioneuroblastoma: illustrative cases.J Neurosurg Case Lessons2021;1:CASE2058 PMCID:PMC9241319

[53] Amit M,Abdelmeguid AS.Patterns of treatment failure in patients with sinonasal mucosal melanoma.Ann Surg Oncol2018;25:1723-9

[54] Tzelnick S,Yacobi D,Popovtzer A.Recurrence patterns and efficacy of surveillance modalities for sinonasal malignancies.Am J Rhinol Allergy2022;36:473-9

[55] Tse E.How I treat NK/T-cell lymphomas.Blood2013;121:4997-5005

[56] Wong KF,Cheung MMC.Bone marrow involvement by nasal NK cell lymphoma at diagnosis is uncommon.Am J Clin Pathol2001;115:266-70

[57] Wang Y,Tian R.PET/CT-based bone-marrow assessment shows potential in replacing routine bone-marrow biopsy in part of patients newly diagnosed with extranodal natural killer/T-cell lymphoma.J Cancer Res Clin Oncol2019;145:2529-39

[58] Nowak B,Jänicke S.Diagnostic evaluation of malignant head and neck cancer by F-18-FDG PET compared to CT/MRI.Nuklearmedizin1999;38:312-8

[59] Ramsay HA,Jekunen AP.Somatostatin receptor imaging of olfactory neuroblastoma.J Laryngol Otol1996;110:1161-3

[60] Bishop JA,Stelow EB.Human papillomavirus-related carcinoma with adenoid cystic-like features: a peculiar variant of head and neck cancer restricted to the sinonasal tract.Am J Surg Pathol2013;37:836-44 PMCID:PMC3653997

[61] Zupancic M.Human papillomavirus-related multiphenotypic sinonasal carcinoma-an even broader tumor entity?.Viruses2021;13:1861 PMCID:PMC8472460

[62] Chang Sing Pang KJW, Mur T, Collins L, Rao SR, Faden DL. Human papillomavirus in sinonasal squamous cell carcinoma: a systematic review and meta-analysis.Cancers2020;13:45 PMCID:PMC7796014

[63] Naegele S,Das D.Detection and monitoring of circulating tumor HPV DNA in HPV-associated sinonasal and nasopharyngeal cancers.JAMA Otolaryngol Head Neck Surg2023;149:179-81 PMCID:PMC9857222

[64] Huang SH,O’Sullivan B.Clinical presentation and outcome of human papillomavirus-positive nasopharyngeal carcinoma in a North American cohort.Cancer2022;128:2908-21

[65] Lewis JS Jr,Bishop JA.Human papillomavirus testing in head and neck carcinomas: guideline from the College of American Pathologists.Arch Pathol Lab Med2018;142:559-97

[66] Kim SJ,Jaccard A.A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis.Lancet Oncol2016;17:389-400

[67] Au WY,Yiu HHY.Clinicopathological features and outcome of late relapses of natural killer cell lymphomas 10-29 years after initial remission.Am J Hematol2010;85:362-3

[68] Kim SJ,Kim BS,Ko YH.Extranodal natural killer/T-cell lymphoma with long-term survival and repeated relapses: does it indicate the presence of indolent subtype?.Korean J Hematol2012;47:202-6 PMCID:PMC3464337

[69] Kommalapati A,Ganti AK.Natural killer/T-cell neoplasms: analysis of incidence, patient characteristics, and survival outcomes in the United States.Clin Lymphoma Myeloma Leuk2018;18:475-9

[70] Dulguerov P,Calcaterra TC.Esthesioneuroblastoma: a meta-analysis and review.Lancet Oncol2001;2:683-90

[71] Girod D,Marentette L.Esthesioneuroblastoma.Head Neck2001;23:500-5